Lambert-Eaton syndrome; a side effect after prior use of botulinum toxin; a breathing disorder such as asthma or emphysema; problems with swallowing; facial muscle weakness (droopy eyelids, weak forehead, trouble raising your eyebrows); a change in the normal appearance of your face; bleeding problems; or; surgery (especially on your face).

› Lambert-Eaton Myasthenic Syndrome (LEMS), or › Autoimmune Hemolytic Anemia, or › Stiff-Person Syndrome (Moersch-Woltman Syndrome), or • History of use of two preferred medications, or • Continuation of prior therapy or use within the past 365 days. Bivigam or Panzyga, may be covered when the criteria listed below are satisfied:

› Lambert-Eaton Myasthenic Syndrome (LEMS), or › Autoimmune Hemolytic Anemia, or › Stiff-Person Syndrome (Moersch-Woltman Syndrome), or • History of use of two preferred medications, or • Continuation of prior therapy or use within the past 365 days. Bivigam or Panzyga, may be covered when the criteria listed below are satisfied:

Lambert-Eaton syndrome; a side effect after prior use of botulinum toxin; a breathing disorder such as asthma or emphysema; problems with swallowing; facial muscle weakness (droopy eyelids, weak forehead, trouble raising your eyebrows); bleeding problems; heart disease; or; surgery (especially on your face).